<DOC>
	<DOCNO>NCT00446498</DOCNO>
	<brief_summary>To assess intubation rate patient affect severe cardiogenic pulmonary edema treat CPAP NPPV .</brief_summary>
	<brief_title>CPAP Versus NPPV ACPE</brief_title>
	<detailed_description>Background Although non-invasive ventilation show effective treatment acute cardiogenic pulmonary oedema ( ACPO ) , literature still lack multi-centre randomise prospective study compare CPAP NPPV . Aim study ass efficacy safety CPAP NPPV patient ACPO . Methods 80 patient ACPO randomly assign receive CPAP NPPV ( 40 group ) face mask . Inclusion criterion : severe dyspnoea , respiratory rate &gt; 30 , PaO2/FiO2 &lt; 200 , muscle fatigue . Main end-points endotracheal intubation , length ventilation , hospital length stay mortality .</detailed_description>
	<mesh_term>Pulmonary Edema</mesh_term>
	<criteria>rapid onset symptom severe dyspnoea rest respiratory rate &gt; 30 breath per minute use accessory respiratory muscle PaO2/FiO2 &lt; 200 , radiological finding ACPE ST elevation myocardial infarction hemodynamic instability ( systolic arterial pressure &lt; 90 mmHg need immediate endotracheal intubation ( respiratory arrest , bradypnea inability protect airway , impaired sensorium ( agitation unconsciousness inability clear secretion , respiratory tract infection chronic obstructive pulmonary disease ( COPD ) exacerbation , chronic respiratory failure necessitate longterm oxygen therapy pulmonary embolism , pneumonia , recent oesophagealgastric surgery gastrointestinal bleeding facial deformity haematological malignancy cancer Eastern Cooperative Oncology Group ( ECOG ) performance status â‰¥ 2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>